ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psychoactive Substances Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7F10469
Home | Market Reports | Sensitive Subjects
Global Psychoactive Substances Market Insights Forecast to 2028
BUY CHAPTERS

Global Psychoactive Substances Market Research Report 2025

Code: QYRE-Auto-7F10469
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Zynerba Pharmaceuticals
GW Pharmaceuticals Plc
Teewinot Life Sciences
Cannabics Pharmaceuticals Inc
Tilray
Cyrelian
Enecta.
GD Pharma
Cape Bouvard Technologies Pty Ltd
AusCann Group Holdings Pty Ltd.
Alpha-CAT
MedReleaf Australia

Psychoactive Substances Market

The global market for Psychoactive Substances was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Psychoactive Substances is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Psychoactive Substances is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Psychoactive Substances in Cancer is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Psychoactive Substances include Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta., Teewinot Life Sciences, GD Pharma, Cape Bouvard Technologies Pty Ltd, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc., Alpha-CAT, Tilray, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Psychoactive Substances, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psychoactive Substances.
The Psychoactive Substances market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psychoactive Substances market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psychoactive Substances companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Psychoactive Substances Market Report

Report Metric Details
Report Name Psychoactive Substances Market
Segment by Type
  • Stimulants
  • Cannabinoids
  • Hallucinogens
  • Depressants
Segment by Application
  • Cancer
  • Neuropathic Disorders
  • Spasticity
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta., Teewinot Life Sciences, GD Pharma, Cape Bouvard Technologies Pty Ltd, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc., Alpha-CAT, Tilray, Cyrelian Pty Ltd., MedReleaf Australia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Psychoactive Substances company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Psychoactive Substances Market report?

Ans: The main players in the Psychoactive Substances Market are Zynerba Pharmaceuticals, GW Pharmaceuticals PLC., Enecta., Teewinot Life Sciences, GD Pharma, Cape Bouvard Technologies Pty Ltd, AusCann Group Holdings Pty Ltd., Cannabics Pharmaceuticals Inc., Alpha-CAT, Tilray, Cyrelian Pty Ltd., MedReleaf Australia

What are the Application segmentation covered in the Psychoactive Substances Market report?

Ans: The Applications covered in the Psychoactive Substances Market report are Cancer, Neuropathic Disorders, Spasticity

What are the Type segmentation covered in the Psychoactive Substances Market report?

Ans: The Types covered in the Psychoactive Substances Market report are Stimulants, Cannabinoids, Hallucinogens, Depressants

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychoactive Substances Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Stimulants
1.2.3 Cannabinoids
1.2.4 Hallucinogens
1.2.5 Depressants
1.3 Market by Application
1.3.1 Global Psychoactive Substances Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Neuropathic Disorders
1.3.4 Spasticity
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psychoactive Substances Market Perspective (2020-2031)
2.2 Global Psychoactive Substances Growth Trends by Region
2.2.1 Global Psychoactive Substances Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psychoactive Substances Historic Market Size by Region (2020-2025)
2.2.3 Psychoactive Substances Forecasted Market Size by Region (2026-2031)
2.3 Psychoactive Substances Market Dynamics
2.3.1 Psychoactive Substances Industry Trends
2.3.2 Psychoactive Substances Market Drivers
2.3.3 Psychoactive Substances Market Challenges
2.3.4 Psychoactive Substances Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psychoactive Substances Players by Revenue
3.1.1 Global Top Psychoactive Substances Players by Revenue (2020-2025)
3.1.2 Global Psychoactive Substances Revenue Market Share by Players (2020-2025)
3.2 Global Psychoactive Substances Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psychoactive Substances Revenue
3.4 Global Psychoactive Substances Market Concentration Ratio
3.4.1 Global Psychoactive Substances Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychoactive Substances Revenue in 2024
3.5 Global Key Players of Psychoactive Substances Head office and Area Served
3.6 Global Key Players of Psychoactive Substances, Product and Application
3.7 Global Key Players of Psychoactive Substances, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psychoactive Substances Breakdown Data by Type
4.1 Global Psychoactive Substances Historic Market Size by Type (2020-2025)
4.2 Global Psychoactive Substances Forecasted Market Size by Type (2026-2031)
5 Psychoactive Substances Breakdown Data by Application
5.1 Global Psychoactive Substances Historic Market Size by Application (2020-2025)
5.2 Global Psychoactive Substances Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psychoactive Substances Market Size (2020-2031)
6.2 North America Psychoactive Substances Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psychoactive Substances Market Size by Country (2020-2025)
6.4 North America Psychoactive Substances Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psychoactive Substances Market Size (2020-2031)
7.2 Europe Psychoactive Substances Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psychoactive Substances Market Size by Country (2020-2025)
7.4 Europe Psychoactive Substances Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psychoactive Substances Market Size (2020-2031)
8.2 Asia-Pacific Psychoactive Substances Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psychoactive Substances Market Size by Region (2020-2025)
8.4 Asia-Pacific Psychoactive Substances Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psychoactive Substances Market Size (2020-2031)
9.2 Latin America Psychoactive Substances Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psychoactive Substances Market Size by Country (2020-2025)
9.4 Latin America Psychoactive Substances Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psychoactive Substances Market Size (2020-2031)
10.2 Middle East & Africa Psychoactive Substances Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psychoactive Substances Market Size by Country (2020-2025)
10.4 Middle East & Africa Psychoactive Substances Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zynerba Pharmaceuticals
11.1.1 Zynerba Pharmaceuticals Company Details
11.1.2 Zynerba Pharmaceuticals Business Overview
11.1.3 Zynerba Pharmaceuticals Psychoactive Substances Introduction
11.1.4 Zynerba Pharmaceuticals Revenue in Psychoactive Substances Business (2020-2025)
11.1.5 Zynerba Pharmaceuticals Recent Development
11.2 GW Pharmaceuticals PLC.
11.2.1 GW Pharmaceuticals PLC. Company Details
11.2.2 GW Pharmaceuticals PLC. Business Overview
11.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Introduction
11.2.4 GW Pharmaceuticals PLC. Revenue in Psychoactive Substances Business (2020-2025)
11.2.5 GW Pharmaceuticals PLC. Recent Development
11.3 Enecta.
11.3.1 Enecta. Company Details
11.3.2 Enecta. Business Overview
11.3.3 Enecta. Psychoactive Substances Introduction
11.3.4 Enecta. Revenue in Psychoactive Substances Business (2020-2025)
11.3.5 Enecta. Recent Development
11.4 Teewinot Life Sciences
11.4.1 Teewinot Life Sciences Company Details
11.4.2 Teewinot Life Sciences Business Overview
11.4.3 Teewinot Life Sciences Psychoactive Substances Introduction
11.4.4 Teewinot Life Sciences Revenue in Psychoactive Substances Business (2020-2025)
11.4.5 Teewinot Life Sciences Recent Development
11.5 GD Pharma
11.5.1 GD Pharma Company Details
11.5.2 GD Pharma Business Overview
11.5.3 GD Pharma Psychoactive Substances Introduction
11.5.4 GD Pharma Revenue in Psychoactive Substances Business (2020-2025)
11.5.5 GD Pharma Recent Development
11.6 Cape Bouvard Technologies Pty Ltd
11.6.1 Cape Bouvard Technologies Pty Ltd Company Details
11.6.2 Cape Bouvard Technologies Pty Ltd Business Overview
11.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Introduction
11.6.4 Cape Bouvard Technologies Pty Ltd Revenue in Psychoactive Substances Business (2020-2025)
11.6.5 Cape Bouvard Technologies Pty Ltd Recent Development
11.7 AusCann Group Holdings Pty Ltd.
11.7.1 AusCann Group Holdings Pty Ltd. Company Details
11.7.2 AusCann Group Holdings Pty Ltd. Business Overview
11.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Introduction
11.7.4 AusCann Group Holdings Pty Ltd. Revenue in Psychoactive Substances Business (2020-2025)
11.7.5 AusCann Group Holdings Pty Ltd. Recent Development
11.8 Cannabics Pharmaceuticals Inc.
11.8.1 Cannabics Pharmaceuticals Inc. Company Details
11.8.2 Cannabics Pharmaceuticals Inc. Business Overview
11.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Introduction
11.8.4 Cannabics Pharmaceuticals Inc. Revenue in Psychoactive Substances Business (2020-2025)
11.8.5 Cannabics Pharmaceuticals Inc. Recent Development
11.9 Alpha-CAT
11.9.1 Alpha-CAT Company Details
11.9.2 Alpha-CAT Business Overview
11.9.3 Alpha-CAT Psychoactive Substances Introduction
11.9.4 Alpha-CAT Revenue in Psychoactive Substances Business (2020-2025)
11.9.5 Alpha-CAT Recent Development
11.10 Tilray
11.10.1 Tilray Company Details
11.10.2 Tilray Business Overview
11.10.3 Tilray Psychoactive Substances Introduction
11.10.4 Tilray Revenue in Psychoactive Substances Business (2020-2025)
11.10.5 Tilray Recent Development
11.11 Cyrelian Pty Ltd.
11.11.1 Cyrelian Pty Ltd. Company Details
11.11.2 Cyrelian Pty Ltd. Business Overview
11.11.3 Cyrelian Pty Ltd. Psychoactive Substances Introduction
11.11.4 Cyrelian Pty Ltd. Revenue in Psychoactive Substances Business (2020-2025)
11.11.5 Cyrelian Pty Ltd. Recent Development
11.12 MedReleaf Australia
11.12.1 MedReleaf Australia Company Details
11.12.2 MedReleaf Australia Business Overview
11.12.3 MedReleaf Australia Psychoactive Substances Introduction
11.12.4 MedReleaf Australia Revenue in Psychoactive Substances Business (2020-2025)
11.12.5 MedReleaf Australia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Zynerba Pharmaceuticals
GW Pharmaceuticals Plc
Teewinot Life Sciences
Cannabics Pharmaceuticals Inc
Tilray
Cyrelian
Enecta.
GD Pharma
Cape Bouvard Technologies Pty Ltd
AusCann Group Holdings Pty Ltd.
Alpha-CAT
MedReleaf Australia
List of Tables
 Table 1. Global Psychoactive Substances Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Stimulants
 Table 3. Key Players of Cannabinoids
 Table 4. Key Players of Hallucinogens
 Table 5. Key Players of Depressants
 Table 6. Global Psychoactive Substances Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Psychoactive Substances Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Psychoactive Substances Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Psychoactive Substances Market Share by Region (2020-2025)
 Table 10. Global Psychoactive Substances Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Psychoactive Substances Market Share by Region (2026-2031)
 Table 12. Psychoactive Substances Market Trends
 Table 13. Psychoactive Substances Market Drivers
 Table 14. Psychoactive Substances Market Challenges
 Table 15. Psychoactive Substances Market Restraints
 Table 16. Global Psychoactive Substances Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Psychoactive Substances Market Share by Players (2020-2025)
 Table 18. Global Top Psychoactive Substances Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2024)
 Table 19. Ranking of Global Top Psychoactive Substances Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Psychoactive Substances Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Psychoactive Substances, Headquarters and Area Served
 Table 22. Global Key Players of Psychoactive Substances, Product and Application
 Table 23. Global Key Players of Psychoactive Substances, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Psychoactive Substances Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Psychoactive Substances Revenue Market Share by Type (2020-2025)
 Table 27. Global Psychoactive Substances Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Psychoactive Substances Revenue Market Share by Type (2026-2031)
 Table 29. Global Psychoactive Substances Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Psychoactive Substances Revenue Market Share by Application (2020-2025)
 Table 31. Global Psychoactive Substances Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Psychoactive Substances Revenue Market Share by Application (2026-2031)
 Table 33. North America Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Psychoactive Substances Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Psychoactive Substances Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Psychoactive Substances Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Psychoactive Substances Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Psychoactive Substances Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Psychoactive Substances Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Psychoactive Substances Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Psychoactive Substances Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Psychoactive Substances Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Psychoactive Substances Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Psychoactive Substances Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Psychoactive Substances Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Zynerba Pharmaceuticals Company Details
 Table 49. Zynerba Pharmaceuticals Business Overview
 Table 50. Zynerba Pharmaceuticals Psychoactive Substances Product
 Table 51. Zynerba Pharmaceuticals Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 52. Zynerba Pharmaceuticals Recent Development
 Table 53. GW Pharmaceuticals PLC. Company Details
 Table 54. GW Pharmaceuticals PLC. Business Overview
 Table 55. GW Pharmaceuticals PLC. Psychoactive Substances Product
 Table 56. GW Pharmaceuticals PLC. Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 57. GW Pharmaceuticals PLC. Recent Development
 Table 58. Enecta. Company Details
 Table 59. Enecta. Business Overview
 Table 60. Enecta. Psychoactive Substances Product
 Table 61. Enecta. Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 62. Enecta. Recent Development
 Table 63. Teewinot Life Sciences Company Details
 Table 64. Teewinot Life Sciences Business Overview
 Table 65. Teewinot Life Sciences Psychoactive Substances Product
 Table 66. Teewinot Life Sciences Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 67. Teewinot Life Sciences Recent Development
 Table 68. GD Pharma Company Details
 Table 69. GD Pharma Business Overview
 Table 70. GD Pharma Psychoactive Substances Product
 Table 71. GD Pharma Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 72. GD Pharma Recent Development
 Table 73. Cape Bouvard Technologies Pty Ltd Company Details
 Table 74. Cape Bouvard Technologies Pty Ltd Business Overview
 Table 75. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product
 Table 76. Cape Bouvard Technologies Pty Ltd Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 77. Cape Bouvard Technologies Pty Ltd Recent Development
 Table 78. AusCann Group Holdings Pty Ltd. Company Details
 Table 79. AusCann Group Holdings Pty Ltd. Business Overview
 Table 80. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product
 Table 81. AusCann Group Holdings Pty Ltd. Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 82. AusCann Group Holdings Pty Ltd. Recent Development
 Table 83. Cannabics Pharmaceuticals Inc. Company Details
 Table 84. Cannabics Pharmaceuticals Inc. Business Overview
 Table 85. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product
 Table 86. Cannabics Pharmaceuticals Inc. Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 87. Cannabics Pharmaceuticals Inc. Recent Development
 Table 88. Alpha-CAT Company Details
 Table 89. Alpha-CAT Business Overview
 Table 90. Alpha-CAT Psychoactive Substances Product
 Table 91. Alpha-CAT Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 92. Alpha-CAT Recent Development
 Table 93. Tilray Company Details
 Table 94. Tilray Business Overview
 Table 95. Tilray Psychoactive Substances Product
 Table 96. Tilray Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 97. Tilray Recent Development
 Table 98. Cyrelian Pty Ltd. Company Details
 Table 99. Cyrelian Pty Ltd. Business Overview
 Table 100. Cyrelian Pty Ltd. Psychoactive Substances Product
 Table 101. Cyrelian Pty Ltd. Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 102. Cyrelian Pty Ltd. Recent Development
 Table 103. MedReleaf Australia Company Details
 Table 104. MedReleaf Australia Business Overview
 Table 105. MedReleaf Australia Psychoactive Substances Product
 Table 106. MedReleaf Australia Revenue in Psychoactive Substances Business (2020-2025) & (US$ Million)
 Table 107. MedReleaf Australia Recent Development
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Psychoactive Substances Picture
 Figure 2. Global Psychoactive Substances Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Psychoactive Substances Market Share by Type: 2024 VS 2031
 Figure 4. Stimulants Features
 Figure 5. Cannabinoids Features
 Figure 6. Hallucinogens Features
 Figure 7. Depressants Features
 Figure 8. Global Psychoactive Substances Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Psychoactive Substances Market Share by Application: 2024 VS 2031
 Figure 10. Cancer Case Studies
 Figure 11. Neuropathic Disorders Case Studies
 Figure 12. Spasticity Case Studies
 Figure 13. Psychoactive Substances Report Years Considered
 Figure 14. Global Psychoactive Substances Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Psychoactive Substances Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Psychoactive Substances Market Share by Region: 2024 VS 2031
 Figure 17. Global Psychoactive Substances Market Share by Players in 2024
 Figure 18. Global Top Psychoactive Substances Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psychoactive Substances as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Psychoactive Substances Revenue in 2024
 Figure 20. North America Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Psychoactive Substances Market Share by Country (2020-2031)
 Figure 22. United States Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Psychoactive Substances Market Share by Country (2020-2031)
 Figure 26. Germany Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Psychoactive Substances Market Share by Region (2020-2031)
 Figure 34. China Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Psychoactive Substances Market Share by Country (2020-2031)
 Figure 42. Mexico Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Psychoactive Substances Market Share by Country (2020-2031)
 Figure 46. Turkey Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Psychoactive Substances Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Zynerba Pharmaceuticals Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 50. GW Pharmaceuticals PLC. Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 51. Enecta. Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 52. Teewinot Life Sciences Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 53. GD Pharma Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 54. Cape Bouvard Technologies Pty Ltd Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 55. AusCann Group Holdings Pty Ltd. Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 56. Cannabics Pharmaceuticals Inc. Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 57. Alpha-CAT Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 58. Tilray Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 59. Cyrelian Pty Ltd. Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 60. MedReleaf Australia Revenue Growth Rate in Psychoactive Substances Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Global New Psychoactive Substance Market Research Report 2024
Global Psychotherapeutics Drugs Market Research Report 2024
Global Cannabis Drug Market Research Report 2024
Global Psychotherapeutic Drugs Market Research Report 2024
Psychotropic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psychobiotics Market Research Report 2024
Global Biogenic Stimulant Market Research Report 2024
Global Recreational Marijuana Market Research Report 2024
Global Psychiatric and Nervous Drugs Market Research Report 2025
Global Psychobiotic Supplements Market Research Report 2024
Global Alcohol Market Research Report 2024
Recreational Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plant Stimulants Market Research Report 2025
Global Opium Market Research Report 2025
Global Marine based Drug Market Research Report 2024
Global Central Nervous System CNS Stimulant Drugs Market Insights Forecast to 2030
Global Humic Substances Market Research Report 2025
Global Central Nervous System CNS Stimulants Market Research Report 2024
Global Propyl Alcohol Market Research Report 2025
Global Phenothiazine Market Research Report 2024

RELATED REPORTS

Global Ballistic Targeting System Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3L6393
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Non-lethal Grenades Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-38D19545
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Gun Shop Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5Y2404
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Army Knives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20A1573
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions